Integra Lifesciences Holdings Corp (NAS:IART)
$ 24.8 -0.64 (-2.51%) Market Cap: 1.91 Bil Enterprise Value: 3.68 Bil PE Ratio: 0 PB Ratio: 1.26 GF Score: 71/100

Integra Lifesciences Holdings Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 09:30PM GMT
Release Date Price: $67.67 (+0.73%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to have Integra as our next company presenting. We're going to have Glenn Coleman start off, COO. We're going to have Jan De Witte do presentation afterwards, new CEO. And then Carrie Anderson, the CFO, is going to join us afterwards for some Q&A.

So with that, Glenn, if you just want to make sure you're not on mute, and I'll turn it over to you.

Glenn G. Coleman
Integra LifeSciences Holdings Corporation - Executive VP & COO

Great. Thank you, Robbie. Good afternoon, everyone. We are delighted to be here this afternoon. As Robbie mentioned, I'm Glenn Coleman, Executive Vice President and Chief Operating Officer at Integra. With me today is our new President and Chief Executive Officer, Jan De Witte. He's going to give an update on his first month at Integra and our strategic priorities.

So if you go to the next slide, please. But first, please know our safe harbor disclosure. As it

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot